Strapped for cash, Lombard Medical defaults on loan

From Medical Design & Outsourcing

• Medtech issues again take center stage in Minn. Congressional races
  The medical device industry is yet again positioned to play a major role in Minnesota congressional races. Incumbent Rep. Erik Paulsen (R-Minn.), who has been a longtime supporter of the medtech industry and led numerous attempts to repeal the medical device tax, is facing a tough re-election campaign. Paulsen is facing off against 48-year-old liquor… […]
• These 10 medtech companies care a lot about research
  These 10 medical device companies spent the largest portion of their budgets on research and development. Here’s a look at what they produced. Each year, Medical Design & Outsourcing compiles a list of the top 100 medical device companies across the globe and ranks the companies based on annual revenue for the most recent fiscal… […]
• DeviceTalks Boston: 5 medtech startups you need to know
  From an individually tailored intra-corneal implant to an improved heart pump for open-heart surgery to new exoskeleton technology, there was a variety of medtech to check out during MassMEDIC’s recent Medtech Showcase. The 20th annual showcase, held last week at DeviceTalks Boston, provided a chance for a batch of 20 companies from around the world… […]
• New eye health companies gain funders’ focus
  Startups pioneering less-invasive technologies to treat common eye diseases are changing the outlook for both patients and the industry. A new study by CB Insights revealed that investors have been pouring money into smaller companies in 2017 and 2018, with some FDA approvals to begin marketing their technologies and treatments. These firms are eyeing conditions… […]
• Where medtech is putting its money this November
  Republicans reaped nearly $3.3 million in federal political contributions from the medtech industry in the 2017-18 election cycle, compared with $1.85 million for Democrats, according to data collected by the Center for Responsive Politics, a nonprofit campaign finance watchdog group. Medtech has “historically been a little more Republican than the average industry,” said Andrew Mayersohn,… […]
• India regulators update medical device and IVD oversight programs
  By Stewart Eisenhart, Emergo Group Indian regulators have recently announced several updates regarding their medical device and IVD oversight programs. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do not necessarily reflect those of MedicalDesignandOutsourcing.com or its employees. The post India […]
• Smith & Nephew launches portable negative pressure wound therapy system
  Smith & Nephew announced today that it has launched its Pico 7Y single-use negative pressure wound therapy system (sNPWT) in Europe. The system features AirLock technology and includes an integrated Y extension that allows for two dressings to be used from one pump to allow for two wounds to be treated at the same time.… […]
• What is the difference between DC brushed and brushless motors?
  Here is an overview of the factors you’ll need to consider when deciding between a DC brushed or brushless motor. By Carsten Horn, Maxon Motor The key difference between brushed and brushless motors is service life. The service life of a brush motor is shorter and limited by wear of the brushes, while a brushless… […]
• Teleflex, Arcis enter agreement for cancer diagnostics
  Cancer-detection company Arcis Biotechnology said today it has signed an agreement allowing Teleflex (NYSE:TFX) to use Arcis’ advanced nucleic acid sample preparation chemistry in the development of a novel technology. Daresbury, England-based Arcis’ diagnostics use a two-step nucleic acid extraction and preservation technology. The company said it has an extensive patent portfolio covering DNA and RNA extraction… […]
• Neovasc touts Tiara TMVR success rate in study
  A small study of the Neovasc (NSDQ:NVCN) Tiara transcatheter mitral valve replacement (TMVR) in high-risk patients revealed a 100% procedural success rate and immediate elimination of mitral regurgitation. Published in Circulation: Cardiovascular Interventions, the study also showed no death, myocardial infarction, stroke, major bleeding, or access site complications at 30 days. The twelve patients in the study had had a previous… […]
• Bard’s peripheral artery stent exceeds acceptable restenosis rate
  C.R. Bard (NYSE:BCR) has notified buyers of its LifeStream covered iliac stent of a higher-than-anticipated restenosis rate among patients. The field notice issued by Bard, parent company BD and Irish catheter-maker ClearStream Technologies said the restenosis rate of 0.04% exceeds the acceptable failure rate of 0.01%. An unspecified number of restenosis complaints was reported following implantation of… […]